Technology News

A number of articles on new assistive technology in optometry were featured on Healio this year, with AI-driven reading products and apps to assist people with low vision.

Patients with concussion who underwent testing with eye-tracking technology had lower saccade performance, supporting the use of these tests to help guide rehabilitation for concussion, according to research in Optometry and Vision Science.

Azalea Vision announced the first on-eye test of its ALMA proprietary smart contact lens, which is designed to offer a nonsurgical solution for patients with keratoconus, corneal irregularities, photophobia and presbyopia.

The self-measurement iCare Home2 tonometer may be reliable for most eyes and clinical settings, although central corneal thickness measurements are recommended before use, according to research published in the Journal of Glaucoma.

A new study has shown that Orbis International’s online course helps nonophthalmic health care workers, who are already trained to recognize diabetic retinopathy, identify signs of glaucoma comparable to ophthalmologists.

Despite advances in research on OCT biomarkers of diabetic macular edema, a standardized classification and grading system is still necessary to fill knowledge gaps, according to a recently published review.

Ocutrx Technologies has released its OcuLenz augmented reality/extended reality headset, which is designed to enhance visual clarity for people with advanced macular degeneration.

NEW ORLEANS — Visual assistive apps may be an important rehabilitation tool for older adults with low vision, according to Nicole Ross, OD, MSc, FAAO, from the New England College of Optometry, who presented at Academy ’23.

OrCam Technologies has launched its OrCam Read 3, a device that uses artificial intelligence to read text aloud for people with vision loss and reading difficulties.

Lumenis announced the launch of OptiPlus, its new dual-frequency radiofrequency device that delivers heat across different tissue layers to increase blood circulation and target dry eye inflammation due to meibomian gland dysfunction.